Past Speakers

The speakers are subject to change.

Co-Chairs

Dominic Adair

Partner
Bristows LLP (U.K)

Remedies and Alternative Measures: Injunctions, Corrective Measures and Rules on Procurement of Evidence

May 31, 2022 • 3:00 pm

Bert Oosting

Partner
Hogan Lovells

Co-Chairs’ Opening Remarks

May 31, 2022 • 9:00 am

Esteemed Faculty

António Andrade

Partner
Abreu Advogados

Strategies for Patent Enforcement: Protecting Patent Rights and the Procedures to Enforce Them

May 30, 2022 • 2:30 pm

Steven Baldwin

Partner
Kirkland & Ellis LLP

European Supplementary Protection Certificates (SPCs): Scope, Duration and Requirements

May 30, 2022 • 11:30 am

Eran Bareket

Partner, Head of Legal Practice
Gilat, Bareket & Co., Attorneys at Law

Patent Enforcement Liability Towards Third Parties: Liability and Unjust Enrichment on Retrospectively Invalid Patents

May 31, 2022 • 11:30 am

Laëtitia Bénard

Partner
Allen & Overy LLP

Strategies for Patent Enforcement: Protecting Patent Rights and the Procedures to Enforce Them

May 30, 2022 • 2:30 pm

Richard Bonneau

Executive Director
Prescient Design, A Genentech Accelerator

Artificial Intelligence, Data and Drug Development: Accelerating Drug Discovery and Development

May 31, 2022 • 2:00 pm

Sara Burghart

Lead IP Litigation Counsel
Global Litigation & Launch – Global IP
Sandoz International GmbH (DEU)

Second Medical Use: Reconciling Infringement and Enforcement

May 30, 2022 • 4:30 pm

Sabrina Duschner

Head of Patent Litigation Strategy
Fresenius Kabi

Plausibility, Sufficiency, and Inventive Step: Considerations for Formulation and Combination Patents in Europe

May 30, 2022 • 10:00 am

Dr Penny Gilbert

Partner
Powell Gilbert LLP

Strategies for Patent Enforcement: Protecting Patent Rights and the Procedures to Enforce Them

May 30, 2022 • 2:30 pm

Professor Dr. Maximilian Haedicke

Professor of Intellectual Property Law
Freiburg University
(Former Judge at Higher Regional Court of Duesseldorf)

Alternative Dispute Resolution: The Shift from Ordinary Proceedings Towards ADR

May 31, 2022 • 4:00 pm

Jochen Herr

Partner
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Preparing for the Unitary Patent and the Unified Patent Court: Ratification, Implementation, and Protocols

May 30, 2022 • 9:10 am

Rieke Kaup

Case Handler
European Commission

Global Strategies for Biosimilars and Innovator Biologics: From Patent Protection to Cost and Market Access

May 31, 2022 • 9:10 am

Daan de Lange

Partner
Brinkhof Advocaten

Compulsory Licensing: Access to Medicines, The TRIPS Agreement and Vaccines

May 31, 2022 • 10:10 am

Otto Licks

Partner
Licks Attorneys

Global Strategies for Biosimilars and Innovator Biologics: From Patent Protection to Cost and Market Access

May 31, 2022 • 9:10 am

Peter Ling

Partner
Lenz & Staehelin

Compulsory Licensing: Access to Medicines, The TRIPS Agreement and Vaccines

May 31, 2022 • 10:10 am

Dr. Philipp Marchand

Partner
Vossius & Partner

Artificial Intelligence, Data and Drug Development: Accelerating Drug Discovery and Development

May 31, 2022 • 2:00 pm

Benjamin May

Partner
ARAMIS Société d'Avocats

Remedies and Alternative Measures: Injunctions, Corrective Measures and Rules on Procurement of Evidence

May 31, 2022 • 3:00 pm

Jean-Hyacinthe de Mitry

Partner
Gide Loyrette Nouel A.A.R.P.I

Patent Enforcement Liability Towards Third Parties: Liability and Unjust Enrichment on Retrospectively Invalid Patents

May 31, 2022 • 11:30 am

Miquel Montañá

Partner
Clifford Chance S.l.

Josep Montefuso

Partner
Clifford Chance

Second Medical Use: Reconciling Infringement and Enforcement

May 30, 2022 • 4:30 pm

Domien Op de Beeck

Partner
Bird & Bird

Preparing for the Unitary Patent and the Unified Patent Court: Ratification, Implementation, and Protocols

May 30, 2022 • 9:10 am

Heli Pihlajamaa

Director
European Patent Office

Global Strategies for Biosimilars and Innovator Biologics: From Patent Protection to Cost and Market Access

May 31, 2022 • 9:10 am

André Pohlmann

Member of the 5th Board of Appeal
European Union Intellectual Property Office

Dr. Kai Rüting

Partner
Vossius & Partner

Remedies and Alternative Measures: Injunctions, Corrective Measures and Rules on Procurement of Evidence

May 31, 2022 • 3:00 pm

Sture Rygaard

Partner
Pleasner

European Supplementary Protection Certificates (SPCs): Scope, Duration and Requirements

May 30, 2022 • 11:30 am

Peter Silverman

EVP, General Counsel and Head of Utrecht
Merus N.V.

Artificial Intelligence, Data and Drug Development: Accelerating Drug Discovery and Development

May 31, 2022 • 2:00 pm

Shohta Ueno, PhD

Director, Dispute Resolution
Regeneron UK Ltd

Global Strategies for Biosimilars and Innovator Biologics: From Patent Protection to Cost and Market Access

May 31, 2022 • 9:10 am

Selma Ünlü

Senior Partner
NSN Law Firm

Remedies and Alternative Measures: Injunctions, Corrective Measures and Rules on Procurement of Evidence

May 31, 2022 • 3:00 pm

Ruud van der Velden

Partner
Hogan Lovells

Patent Enforcement Liability Towards Third Parties: Liability and Unjust Enrichment on Retrospectively Invalid Patents

May 31, 2022 • 11:30 am

Ruud van der Velden

Partner
Hogan Lovells

Patent Enforcement Liability Towards Third Parties: Liability and Unjust Enrichment on Retrospectively Invalid Patents

May 31, 2022 • 11:30 am

Peter van Schijndel

Partner
Hoyng Rokh Monegier

Global Strategies for Biosimilars and Innovator Biologics: From Patent Protection to Cost and Market Access

May 31, 2022 • 9:10 am

Mikkel Vittrup

Partner
Plesner

Jonas Westerberg

Partner
Westerberg & Partners Advokatbyrå AB

Second Medical Use: Reconciling Infringement and Enforcement

May 30, 2022 • 4:30 pm